Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Martin Daniel C., Directeur Commercial. Insider active across 1 company, notably Deciphera Pharmaceuticals, Inc.. In total, 13 filings have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €296k. History available since 15 December 2021. The latest transaction was filed on 15 February 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations
Martin Daniel C. is Directeur Commercial and Chief Commercial Officer at Deciphera Pharmaceuticals, Inc. He has 13 filings in total, and across the 13 sampled filings there were only sales, for a combined EUR 295593, over the period from 2021-12-17 to 2024-06-11. The modal transaction nature is Attribution.